相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease
Yusuke Yamamoto et al.
HEPATOLOGY COMMUNICATIONS (2020)
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Michael Teufel et al.
GASTROENTEROLOGY (2019)
Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma
Makoto Chuma et al.
HEPATOLOGY RESEARCH (2019)
Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma
Anna Weis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Chunfeng Qu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
Gabriele De Rubis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma
Juqiang Han et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Next-Generation Cancer Immunotherapy Targeting Glypican-3
Yasuhiro Shimizu et al.
FRONTIERS IN ONCOLOGY (2019)
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O. Kaseb et al.
CLINICAL CANCER RESEARCH (2019)
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
Jessica Howell et al.
EUROPEAN JOURNAL OF CANCER (2019)
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
Jiabin Cai et al.
GUT (2019)
Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
Yu Young Joo et al.
SCIENTIFIC REPORTS (2019)
Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma
Yu Xiong et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
Marianna Alunni-Fabbroni et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization
Hamdy E. A. Ali et al.
CLINICAL BIOCHEMISTRY (2019)
Circulating microRNAs for the diagnosis of hepatocellular carcinoma
Cheng Peng et al.
DIGESTIVE AND LIVER DISEASE (2019)
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Jesus M. Banales et al.
HEPATOLOGY (2019)
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
Mathilde Mathieu et al.
NATURE CELL BIOLOGY (2019)
Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application
Sabine K. Urban et al.
SEMINARS IN LIVER DISEASE (2019)
Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018
Jesus M. Banales et al.
HEPATOLOGY COMMUNICATIONS (2019)
Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA
Ryan A. Hlady et al.
THERANOSTICS (2019)
Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population
Munirah Alsaleh et al.
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2019)
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Fubo Zhou et al.
MEDICINAL RESEARCH REVIEWS (2018)
Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
Bee Luan Khoo et al.
NATURE PROTOCOLS (2018)
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: a pilot study
C. K. Y. Ng et al.
ANNALS OF ONCOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
Elizabeth Brunt et al.
HEPATOLOGY (2018)
Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma
Linlin Yan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
Francesca Pezzuto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Soon Sun Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2018)
A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma
Colin M. Court et al.
LIVER TRANSPLANTATION (2018)
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Ismail Labgaa et al.
ONCOGENE (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Liquid biopsies for hepatocellular carcinoma
Ying-Hsiu Su et al.
TRANSLATIONAL RESEARCH (2018)
Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
Yang An et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
Farzaneh Moshiri et al.
Oncotarget (2018)
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
Yurong Wang et al.
CANCER MEDICINE (2018)
Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma
Chunwen Pu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
Abderrahim Oussalah et al.
EBIOMEDICINE (2018)
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Jie Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Circulating tumor DNA - Current state of play and future perspectives
Gabriele De Rubis et al.
PHARMACOLOGICAL RESEARCH (2018)
High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma
Delia D'Avola et al.
SCIENTIFIC REPORTS (2018)
High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization
Jian Shen et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?
Artur Slomka et al.
FRONTIERS IN IMMUNOLOGY (2018)
Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases
Ling Wei et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Thery et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Contemporary role of liver biopsy in hepatocellular carcinoma
Zeno Sparchez et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Telomerase Reverse Transcriptase Mutations in Plasma DNA in Patients With Hepatocellular Carcinoma or Cirrhosis: Prevalence and Risk Factors
Jingjing Jiao et al.
HEPATOLOGY COMMUNICATIONS (2018)
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
Charlotte K. Y. Ng et al.
FRONTIERS IN MEDICINE (2018)
Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
Chang-Yi Lu et al.
ONCOTARGET (2017)
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma
Kazuya Ofuji et al.
ONCOTARGET (2017)
Serum Extracellular Vesicles Contain Protein Biomarkers for Primary Sclerosing Cholangitis and Cholangiocarcinoma
Ander Arbelaiz et al.
HEPATOLOGY (2017)
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection
Valeria Abbate et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma
Henrike Julich-Haertel et al.
JOURNAL OF HEPATOLOGY (2017)
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang et al.
JOURNAL OF HEPATOLOGY (2017)
Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
Ying Zhang et al.
MEDICINE (2017)
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma A meta-analysis
Chi Sun et al.
MEDICINE (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma
Reetta Holmila et al.
PLOS ONE (2017)
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma
Mark Kalinich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
Bao-Min Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
Wataru Okajima et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
Hyo Jung Cho et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection
Johann von Felden et al.
ONCOTARGET (2017)
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
Xin Guo et al.
ONCOTARGET (2017)
Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles
Yan Ding et al.
ONCOTARGET (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection
Z. J. Liu et al.
NEOPLASMA (2017)
Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma
Xueyan Dong et al.
DISEASE MARKERS (2017)
Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma
Weidong Yuan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis
Francesca Fornari et al.
CLINICAL CANCER RESEARCH (2017)
The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?
Dorota Kwapisz
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection
Yan Zhou et al.
BMC CANCER (2016)
AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis
Junhua Jin et al.
CANCER LETTERS (2016)
Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
Yonghai Lu et al.
CANCER RESEARCH (2016)
Personalized therapy for hepatocellular carcinoma: Where are we now?
Stephen L. Chan et al.
CANCER TREATMENT REVIEWS (2016)
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
Chang-Qing Yin et al.
DISEASE MARKERS (2016)
The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma
Khalda Said Amr et al.
GENE (2016)
An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients
Yong-kang Liu et al.
HEPATOLOGY INTERNATIONAL (2016)
Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma
Ahmed Hassan Fawzi El-Tawdi et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection
Abdel-Rahman Nabawy Zekri et al.
TUMOR BIOLOGY (2016)
Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma
Chunbo Zhuang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function
Wataru Okajima et al.
ONCOTARGET (2016)
Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
Wenjun Liao et al.
ONCOTARGET (2016)
Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment
Shuyi Wang et al.
THERANOSTICS (2016)
Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
Ao Huang et al.
JOURNAL OF CANCER (2016)
Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
Ao Huang et al.
JOURNAL OF CANCER (2016)
Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
Anne Fages et al.
BMC MEDICINE (2015)
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
T. Kimhofer et al.
BRITISH JOURNAL OF CANCER (2015)
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan et al.
CANCER CELL (2015)
Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis
Jun-Li Fan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation
Hyo Jung Cho et al.
CLINICAL BIOCHEMISTRY (2015)
Translational Implications of Tumor Heterogeneity
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2015)
Update on Biomarkers of Hepatocellular Carcinoma
Roongruedee Chaiteerakij et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats
Wei-hui Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Fifty Years of Discovery of Alpha-Fetoprotein as the First Tumor Marker
Dina Nikulina et al.
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO (2015)
Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
Yoshiki Murakami et al.
SCIENTIFIC REPORTS (2015)
Su2042 Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
Takanori Mukozu et al.
GASTROENTEROLOGY (2015)
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
Carlos J. Pirola et al.
GUT (2015)
Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker Discovery
Yaping Shao et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy
Atsushi Ono et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Discovery and Diagnostic Value of a Novel Oncofetal Protein: Glypican 3
Sean K. Wang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2014)
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Marina Colombo et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
Hepatocellular carcinoma tumour markers: Current role and expectations
Nicole Rich et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis
Yue Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2014)
Metabolomics Study of Hepatocellular Carcinoma: Discovery and Validation of Serum Potential Biomarkers by Using Capillary Electrophoresis-Mass Spectrometry
Jun Zeng et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
Davide Povero et al.
PLOS ONE (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma
J. Tang et al.
CELL DEATH & DISEASE (2014)
Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
Qiang Huang et al.
CANCER RESEARCH (2013)
Sublethal Heat Treatment Promotes Epithelial-Mesenchymal Transition and Enhances the Malignant Potential of Hepatocellular Carcinoma
Shuhei Yoshida et al.
HEPATOLOGY (2013)
Power of Metabolomics in Diagnosis and Biomarker Discovery of Hepatocellular Carcinoma
Xijun Wang et al.
HEPATOLOGY (2013)
MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma
Liang Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
MicroRNAs in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Circulating Tumor Cells
Vicki Plaks et al.
SCIENCE (2013)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
Sufen Shang et al.
HEPATOLOGY (2012)
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases
Shashi Bala et al.
HEPATOLOGY (2012)
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry
Lina Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Metabolic phenotyping in clinical and surgical environments
Jeremy K. Nicholson et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method
Feng Chen et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Glypican-3 A Novel Diagnostic Marker for Hepatocellular Carcinoma and More
Dina H. Kandil et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry
Hao Wu et al.
ANALYTICA CHIMICA ACTA (2009)
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma
Yusuke Yamamoto et al.
BIOMARKERS (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
C. Kut et al.
BRITISH JOURNAL OF CANCER (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Serum tumor markers for detection of hepatocellular carcinoma
Lin Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size
Shinichiro Nakamura et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma
H Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma
T Nakatsura et al.
BIODRUGS (2005)
Frequent EpCam protein expression in human carcinomas
PT Went et al.
HUMAN PATHOLOGY (2004)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
SD Ryder
GUT (2003)
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients
JA Marrero et al.
HEPATOLOGY (2003)
Exosomes:: Composition, biogenesis and function
C Théry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
D Li et al.
CLINICA CHIMICA ACTA (2001)
分享论文
